Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: Formation of virus-like particles useful for immunological and therapeutic studies

Journal of Virology

Volumn 73, Issue 5, 1999, Pages 4465-4469

  Goldmann, Claudia ^a   Petry, Harald ^a   Frye, Stephan ^a   Ast, Oliver ^a   Ebitsch, Susanne ^a   Jentsch, Klaus Dieter ^a   Kaup, Franz Josef ^a   Weber, Frank ^a   Trebst, Corinna ^a   Nisslein, Thomas ^a   Hunsmann, Gerhard ^a   Weber, Thomas ^a,c   Lüke, Wolfgang ^a,b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b GERMAN PRIMATE CENTER   (Germany)

^c Neurological Clinic   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

STRUCTURAL PROTEIN; VIRUS DNA; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; GENE TARGETING; GENE THERAPY; JC VIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS CAPSID; VIRUS PARTICLE; VIRUS RECOMBINANT;

EID: 0032899507     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.5.4465-4469.1999     Document Type: Article

References (24)

1. Atwood, W., K. Ameyami, R. Traub, J. Harms, and E. Major. 1992. Interaction of the human polyomavirus JCV with human B-lytnphocytes. Virology 190:716-723.
2. Barr, M., K. Keck, and H. Aposhian. 1979. Cell-free assembly of a polyoma-like particle from empty capsids and DNA. Virology 96:655-659.
3. Berger, J., and M. Concha. 1995. Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J. Neurovirol. 1:5-18.
4. Epstein, M., Y. Achong, Y. Barr, B. Zajac, G. Henle, and W. Henle. 1966. Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). J. Natl. Cancer Inst. 37:547-559.
5. Foley, G., H. Lazarus, S. Farber, G. Uzman, B. Boone, and R. McCarty. 1965. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 18:522-528.
6. Frye, S., C. Trebst, U. Dittmer, H. Petry, M. Bodemer, G. Hunsmann, T. Weber, and W. Lüke. 1997. Efficient production of JCV in SVG cells and the use of purified viral antigens for analysis of specific humoral and cellular immune response. J. Virol. Methods 63:81-92.
7. Gahéry-Ségard, H., V. Juillard, J. Gaston, R. Lengagne, A. Pavirani, P. Boulanger, and J.-G. Guillet. 1997. Humoral immune response to the capsid components of recombinant adenoviruses: routes of immunization modulate virus-induced Ig subclass shirts. Eur. J. Immunol. 27:653-659.
8. Gahéry-Ségard, H., V. Molinier-Frenkel, C. LeBoulaire, P. Saulnier, P. Opolon, R. Lengagne, E. Gautier, A. LeCesne, L. Zitvogel, A. Venet, C. Schatz, M. Courtney, T. LeChevalier, T. Tursz, J.-G. Guillet, and F. Farace. 1997. Phase I trial of recombinant adenovirus gene transfer in lung cancer: longitudinal study of the immune responses to transgene and viral products. J. Clin. Investig. 100:2218-2226.
9. Gahéry-Ségard, H., F. Farace, D. Godfrin, J. Gaston, R. Lengagne, T. Tursz, P. Boulanger, and J.-G. Guillet. 1998. Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity. J. Virol. 72:2388-2397.
10. Gluzman, Y. 1981. SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23:175-182.
11. Jarrett, W., K. Smith, B. O'Neil, J. Gaukroger, L. Chandrachud, G. Grindlay, G. McGarvie, and M. Campo. 1991. Studies on vaccination against papillomaviruses: prophylactic and therapeutic vaccination with recombinant structural proteins. Virology 184:33-42.
12. Jolly, D. 1994. Viral vector systems for gene therapy. Cancer Gene Ther. 1:51-64.
13. Kirnbauer, R. 1996. Papillomavirus-like particles for serology and vaccine development. Intervirology 39:54-61.
14. Major, E., A. Miller, P. Mourrain, R. Traub, E. DeWidt, and J. Sever. 1985. Establishment of a line of human fetal glial cells that supports JCV multiplication. Proc. Natl. Acad. Sci. USA 82:1257-1261.
15. Major, E. O., K. Amemiya, C. S. Tornatore, S. A. Houff, and J. R. Berger. 1992. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin. Microbiol. Rev. 5:49-73.
16. McCance, D. 1983. Persistence of animal and human papovavirus in renal and nervous tissues. Prog. Clin. Biol. Res. 105:343-357.
17. Polzien, F., J. Scharf, W. Luke, and G. Hunsmann. 1992. CD4-binding of gp130 micelles isolated from SIVagmTYO-7. AIDS Res. Hum. Retroviruses 8:1171-1177.
18. Rieckmann, P., U. Michel, and J. H. Kehrl. 1994. Regulation of JC virus expression in B lymphocytes. J. Virol. 68:217-222.
19. Robb, J., and K. Huebner. 1973. Effect of cell chromosome number on simian virus 40 replication. Exp. Cell Res. 81:120-126.
20. Sapp, M., C. Volpers, and R. Streeck. 1996. Synthesis, properties and applications of papillomavirus-like particles. Intervirology 39:49-53.
21. Van Driel, W., M. Ressing, R. Brandt, R. Toes, G. Fleuren, J. Trimbos, W. Kast, and C. Melief. 1996. The current status of therapeutic HPV vaccine. Ann. Med. 28:471-477.
22. Weber, T., R. Turner, S. Frye, B. Ruf J. Haas, E. Schielke, H. Pohle, W. Lüke, W. Lüer, K. Felgenhauer, and G. Hunsmann. 1994. Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction. J. Infect. Dis. 169:1138-1141.
23. Weber, T., R. Turner, S. Frye, W. Lüke, H. Kretzschmar, W. Lüer, and G. Hunsmann. 1994. Progressive multifocal leukoencephalopathy diagnosed by amplification of JC virus-specific DNA from cerebrospinal fluid. AIDS 8:49-57.
24. Weber, T., C. Trebst, S. Frye, P. Cinque, L. Vago, C. Sindic, W. Schulz-Schaeffer, H. Kretzschmar, W. Enzensberger, G. Hunsmann, and W. Lüke. 1997. Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J. Infect. Dis. 176:250-254.